Access submits additional patent applications for Cobalamin-mediated oral medication delivery technology Gain access to PHARMACEUTICALS, INC. , a biopharmaceutical business leveraging its proprietary drug-delivery platforms to build up treatments in regions of oncology, cancer supportive treatment and diabetes, announced it provides submitted additional patent applications, covering its Cobalamin-mediated oral medication delivery technology formulations of many global top-100 injectable drugs, because of the growing interest surrounding the company’s proprietary oral delivery technology. ‘The CobOral branding and additional patent filings reflect the advanced of curiosity from partners inside our CobOral and CobaCyte drug delivery platforms,’ stated Jeffrey B .